Serum Dickkopf-1 is increased and correlates with reduced bone mineral density in patients with thalassemia-induced osteoporosis. Reduction post-zoledronic acid administration.
about
Treatment for osteoporosis in people with ß-thalassaemiaMolecular Aspects of Bone Resorption in β-Thalassemia MajorZinc supplementation improves bone density in patients with thalassemia: a double-blind, randomized, placebo-controlled trial.Physiopathology of Bone Modifications in β-Thalassemia.Serum dickkopf-1 level in postmenopausal females: correlation with bone mineral density and serum biochemical markers.Bleeding disorders and reduced bone density.Osteoporosis--a risk factor for cardiovascular disease?Bisphosphonates in the management of thalassemia-associated osteoporosis: a systematic review of randomised controlled trials.Neridronate improves bone mineral density and reduces back pain in β-thalassaemia patients with osteoporosis: results from a phase 2, randomized, parallel-arm, open-label study.A complicated disease: what can be done to manage thalassemia major more effectively?Thalassemia-associated osteoporosis: a systematic review on treatment and brief overview of the disease.Effects of teriparatide retreatment in a patient with β-thalassemia major.Acute effects of glucocorticoids on serum markers of osteoclasts, osteoblasts, and osteocytes.Relationship between A163G osteoprotegerin gene polymorphism and other osteoporosis parameters in Roma and non-Roma postmenopausal women in eastern Slovakia.
P2860
Q24186036-DB0B8726-8937-4A69-8478-DB63B9CAE304Q26801066-F7F42DF8-7579-467D-961E-0823D6AB109BQ34941788-6F3AD7FC-996A-42A0-B276-E7780386ABCCQ36014282-CDF9E974-430B-4646-83D3-ADD96F32D26FQ37009964-84161594-85D7-4B9A-800A-73CC111286C3Q37761063-C3DF9ADC-2125-49E1-BF01-A9AD8C4F3E50Q38034388-8F4EE54C-15D1-4D7C-B5C5-18FD259CE016Q38205707-2F20AE9D-8237-4A82-BFC8-578DF30E7F8DQ38471926-3B43A990-1544-4F82-84EE-97DECEFDD55DQ38607875-39CB2AD7-24EE-42BA-8770-A120796AA60BQ38922341-2B9051BB-E8D9-4C62-ACBC-A0EB2962AFC2Q40737431-25F85451-99FA-47D4-91C3-CED28B2EFDCBQ45797594-616862D8-23A2-4633-B346-83A1631BA08CQ47619382-07504D78-AA05-44BF-B869-1CD921CC59CB
P2860
Serum Dickkopf-1 is increased and correlates with reduced bone mineral density in patients with thalassemia-induced osteoporosis. Reduction post-zoledronic acid administration.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Serum Dickkopf-1 is increased ...... oledronic acid administration.
@en
Serum Dickkopf-1 is increased ...... oledronic acid administration.
@nl
type
label
Serum Dickkopf-1 is increased ...... oledronic acid administration.
@en
Serum Dickkopf-1 is increased ...... oledronic acid administration.
@nl
prefLabel
Serum Dickkopf-1 is increased ...... oledronic acid administration.
@en
Serum Dickkopf-1 is increased ...... oledronic acid administration.
@nl
P2093
P2860
P1433
P1476
Serum Dickkopf-1 is increased ...... zoledronic acid administration
@en
P2093
Antonios Bilalis
Athanasios Papatheodorou
Charoula Xirakia
Dimitrios Christoulas
Ersi Voskaridou
Evangelos Terpos
Georgios Boutsikas
Konstantinos Varvagiannis
P2860
P304
P356
10.3324/HAEMA-TOL.2008.000893
10.3324/HAEMATOL.2008.000893
P577
2009-05-01T00:00:00Z